Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial-Reference-Cited by-同舟云学术

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Published:2003-11 Issue:9395 Volume:362 Page:1517-1526
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zajicek John,Fox Patrick,Sanders Hilary,Wright David,Vickery Jane,Nunn Andrew,Thompson Alan

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Multiple sclerosis;Paty,1998

2. Urodynamics and multiple sclerosis;Hinson;Urolog Clin N Am,1996

3. Upper urinary tract abnormalities in multiple sclerosis;Sliwa;Arch Phys Med Rehab,1996

4. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey;Eisenberg;JAMA,1998

5. Utilisation of unconventional treatments by persons with MS: is it alternative or complementary?;Schwartz;Neurology,1999

Cited by 658 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytocannabinoids—Evaluation of their therapeutic role in neuroinflammation;Exploration of Neuroprotective Therapy;2024-08-22

2. Cannabiskonsum und Cannabiskonsumstörungen;Der Nervenarzt;2024-08-12

3. Inpatient dronabinol utilisation: an institutional retrospective study to determine prevalence and indications for clinical application;British Journal of Anaesthesia;2024-07

4. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07

5. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders;Basic & Clinical Pharmacology & Toxicology;2024-03-13